Rivernorth Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Rivernorth Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,549	Closed	-$351	–	468
2023 Q4	$351	Hold	17,549	–	–	﹤0.01%	477
2023 Q3	$1.56K	Hold	17,549	–	–	﹤0.01%	508
2023 Q2	$876	Hold	17,549	–	–	﹤0.01%	562
2023 Q1	$660	Buy	+17,549	New	+$986	﹤0.01%	627

Other funds holding COCHW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Rivernorth Capital Management's COCHW Position: Q1 2024 in Review

Rivernorth Capital Management sold out of Envoy Medical Warrant (COCHW) in Q1 2024, closing a stake of 17,549 shares — an estimated $351 sold.

Rivernorth Capital Management first reported a position in COCHW in Q1 2023 and held it in 4 quarters. The position peaked at $1.56K in Q3 2023. 47 funds tracked by Wall St. Rank hold COCHW as of Q1 2024.

Rivernorth Capital Management reported no remaining Envoy Medical Warrant position as of Q1 2024 after selling out during the quarter.
Rivernorth Capital Management sold 17,549 Envoy Medical Warrant shares in Q1 2024, an estimated $351.
Rivernorth Capital Management first reported a position in Envoy Medical Warrant in Q1 2023 and held it in 4 quarters.
Rivernorth Capital Management's Envoy Medical Warrant position peaked at $1.56K in Q3 2023.
47 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2024.

Based on Rivernorth Capital Management's 13F filing for Q1 2024, filed 15 May 2024.